HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer
Yirui Zhai(Chinese Academy of Medical Sciences & Peking Union Medical College), Lühua Wang(Nankai University), Lujun Zhao(Tianjin Medical University Cancer Institute and Hospital), Bo Chen(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Liming Xu(Fujian Medical University), Qingsong Pang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ming Chen(First Affiliated Hospital Zhejiang University), Honglian Ma(Zhejiang Cancer Hospital), Xiaozhen Wang(AstraZeneca (United States)), Dongming Li(Dalian University), Jun Liang(Peking University), Yujin Xu(Chinese Academy of Sciences), Yu Tang(Jiangnan University), Runye Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhouguang Hui(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 37
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
Genome of the long-living sacred lotus (Nelumbo nucifera Gaertn.)
|Genome biology|2013|430
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i> -Mutated NSCLC
|New England Journal of Medicine|2024|291
Association of Cerebral Deficits With Clinical Symptoms in Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry and Resting State Functional Connectivity Study
|American Journal of Psychiatry|2008|257
Fabrication and Electrochemical Treatment Application of A Novel Lead Dioxide Anode with Superhydrophobic Surfaces, High Oxygen Evolution Potential, and Oxidation Capability
|Environmental Science & Technology|2010|237